Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07ISM
|
||||
Former ID |
DNC000967
|
||||
Drug Name |
MTII Melanotan-II
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Female sexual dysfunction [ICD9: 302.7; ICD10:F52] | Investigative | [536493] | ||
Structure |
Download2D MOL |
||||
Formula |
C50H69N15O9
|
||||
Canonical SMILES |
CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=<br />O)C(NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=C<br />C=CC=C54)C(=O)N)NC(=O)C
|
||||
InChI |
1S/C50H69N15O9/c1-3-4-16-36(59-29(2)66)44(69)65-41-25-42(67)55-20-11-10-18-35(43(51)68)60-47(72)39(23-31-26-57-34-17-9-8-15-33(31)34)63-45(70)37(19-12-21-56-50(52)53)61-46(71)38(22-30-13-6-5-7-14-30)62-48(73)40(64-49(41)74)24-32-27-54-28-58-32/h5-9,13-15,17,26-28,35-41,57H,3-4,10-12,16,18-25H2,1-2H3,(H2,51,68)(H,54,58)(H,55,67)(H,59,66)(H,60,72)(H,61,71)(H,62,73)(H,63,70)(H,64,74)(H,65,69)(H4,52,53,56)/t35-,36-,37-,38+,39-,40-,41-/m0/s1
|
||||
InChIKey |
JDKLPDJLXHXHNV-MFVUMRCOSA-N
|
||||
CAS Number |
CAS 121062-08-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
14890081, 14939041, 16659180, 44423271, 50064256, 50112577, 57335280, 80867774, 93815086, 103481530, 104068740, 104121488, 104407428, 123389854, 134340245, 134343469, 135048952, 135652308, 137274328, 139116892, 142227675, 144240042, 152134073, 152344279, 152344459, 162177756, 162222552, 164828419, 184605715, 187072143, 227296747, 244119246, 249719041, 251915695, 251917045, 252156616, 252351544
|
||||
Target and Pathway | |||||
Target(s) | Melanocortin-4 receptor | Target Info | Agonist | [536493] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Pathway Interaction Database | Syndecan-3-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.